Total Payments
$7,096
2024 Payments
$2,417
Companies
31
Transactions
436
Medicare Patients
1,477
Medicare Billing
$78,485
Payment Breakdown by Category
Food & Beverage$7,088 (99.9%)
Education$8.45 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,088 | 435 | 99.9% |
| Education | $8.45 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,106 | 88 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $699.03 | 40 | $0 (2024) |
| Novo Nordisk Inc | $646.08 | 42 | $0 (2024) |
| Mylan Specialty L.P. | $573.73 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $489.70 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $461.76 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $410.77 | 27 | $0 (2023) |
| Exact Sciences Corporation | $301.90 | 20 | $0 (2024) |
| Lilly USA, LLC | $273.97 | 18 | $0 (2024) |
| ITI, Inc. | $264.16 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,417 | 125 | ABBVIE INC. ($388.83) |
| 2023 | $1,934 | 125 | ABBVIE INC. ($421.10) |
| 2022 | $1,406 | 98 | SANOFI-AVENTIS U.S. LLC ($197.37) |
| 2021 | $1,340 | 88 | GlaxoSmithKline, LLC. ($232.94) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardio-renal | ||||||
| 12/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: PAIN | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Obesity | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Oncology | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 608 | 1,174 | $101,079 | $27,722 |
| 2022 | 11 | 505 | 998 | $107,945 | $26,518 |
| 2021 | 8 | 364 | 555 | $80,503 | $24,245 |
Total Patients
1,477
Total Services
2,727
Medicare Billing
$78,485
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 194 | 342 | $54,720 | $14,920 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $16,802 | $4,790 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 56 | $15,568 | $4,188 | 26.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 30 | $6,000 | $739.24 | 12.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,020 | $729.81 | 71.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,020 | $729.81 | 71.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 77 | $2,618 | $546.84 | 20.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 11 | $880.00 | $413.61 | 47.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 19 | $779.00 | $308.18 | 39.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 40 | 188 | $564.00 | $132.08 | 23.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 11 | $330.00 | $129.03 | 39.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $150.00 | $51.15 | 34.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 18 | 88 | $440.00 | $29.43 | 6.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 40 | 188 | $188.00 | $15.08 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 426 | $68,160 | $18,332 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 54 | $15,012 | $3,675 | 24.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 60 | $12,000 | $1,489 | 12.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $4,290 | $1,258 | 29.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 18 | 18 | $1,440 | $735.73 | 51.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 60 | $2,040 | $442.14 | 21.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 15 | 24 | $984.00 | $391.25 | 39.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 30 | 137 | $1,602 | $103.38 | 6.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 19 | $190.00 | $65.36 | 34.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 41 | $205.00 | $13.04 | 6.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 30 | 147 | $2,022 | $11.88 | 0.6% |
About Amber Mahar, APRN
Amber Mahar, APRN is a Primary Care healthcare provider based in Sallisaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1982203444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amber Mahar, APRN has received a total of $7,096 in payments from pharmaceutical and medical device companies, with $2,417 received in 2024. These payments were reported across 436 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,088).
As a Medicare-enrolled provider, Mahar has provided services to 1,477 Medicare beneficiaries, totaling 2,727 services with total Medicare billing of $78,485. Data is available for 3 years (2021–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Sallisaw, OK
- Active Since 10/25/2020
- Last Updated 10/25/2020
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1982203444
Products in Payments
- VRAYLAR (Drug) $826.13
- FARXIGA (Drug) $493.08
- Kerendia (Drug) $461.76
- CAPLYTA (Drug) $370.46
- SOLIQUA 100/33 (Biological) $369.71
- TRELEGY ELLIPTA (Drug) $352.07
- Cologuard Collection Kit (Device) $301.90
- Yupelri (Drug) $297.21
- NURTEC ODT (Drug) $277.45
- YUPELRI (Drug) $276.52
- Wegovy (Drug) $211.52
- BELSOMRA (Drug) $198.71
- Qelbree (Drug) $196.19
- JARDIANCE (Drug) $194.84
- QULIPTA (Drug) $182.30
- Rybelsus (Drug) $163.28
- Ozempic (Drug) $151.87
- GLASSIA (Biological) $147.71
- AREXVY (Drug) $137.63
- TRULICITY (Drug) $129.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.